Social Media Messaging for Colorectal Cancer Screening
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests how social media messages can encourage colorectal cancer screening. Participants will be divided into groups to determine which messages most effectively raise awareness and motivation for screening. Individuals who identify as white/Caucasian or Black/African American and have not had colorectal cancer may be suitable for this trial. The researchers aim to gather insights from 2,000 participants to improve public health messaging. As an unphased trial, this study provides a unique opportunity to contribute to innovative strategies that could enhance public health communication.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this social media messaging is safe for participants?
Research has shown that sharing health information on social media is generally safe. In one study, a Facebook campaign aimed at lowering colorectal cancer risk was tested, and no harm resulted from the social media content. Another study found that sending health-related messages, such as texts, increased cancer screening rates without any known negative effects.
In this trial, participants will view various social media messages about cancer screening. Similar studies have not identified any safety concerns with these messages. Since this trial focuses on communication methods rather than a new drug or medical procedure, the risks are very low. The main goal is to determine how different messages might influence people's decisions about cancer screening.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how tailored social media messaging can boost colorectal cancer screening rates. Unlike traditional methods, which often rely on direct mail or reminders from healthcare providers, this approach leverages the power and reach of social media to deliver targeted messages. The trial examines different message types, such as those preferred by specific demographic groups, to see which are most effective at encouraging people to get screened. This could lead to more personalized and engaging communication strategies, ultimately increasing screening uptake and early detection of colorectal cancer.
What evidence suggests that this trial's social media messaging could be effective for colorectal cancer screening?
Research has shown that social media can effectively promote cancer screening. This trial will evaluate various social media messaging strategies to encourage colorectal cancer screening. Participants in different treatment arms will receive messages such as Median Ranked, Overall Preferred, Black American Preferred, and White American Preferred. Studies have found social media to be an effective method for sharing information about cancer awareness and screening. For instance, combining social media with personal support, like guidance from a patient navigator, significantly increased colorectal cancer screening rates. Specifically, one study using Facebook messages to promote colorectal cancer screening found promising results in raising awareness and interest. Overall, social media messages can effectively encourage more people to get screened for cancer.16789
Who Is on the Research Team?
Andy King, PhD
Principal Investigator
Huntsman Cancer Institute/ University of Utah
Are You a Good Fit for This Trial?
This trial is for adults aged 45 to 74 who self-identify as either White/Caucasian or Black/African American. It aims to gather preferences on cancer screening messages from a national sample, with an equal number of participants from each racial group.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Survey Experiment
Participants complete a 15-minute survey after being randomly assigned to one of five conditions
Data Analysis
The study team receives a de-identified data file for analysis after all participants complete the survey
Follow-up
Participants are monitored for any additional information sharing behavior and intentions to adhere to screening recommendations
What Are the Treatments Tested in This Trial?
Interventions
- Social Media and Cancer Screening Information
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
AmeriSpeak - NORC
Collaborator